We would love to hear your thoughts about our site and services, please take our survey here.
Quell was co founded by Syncona in 2019 who therefore have a big interest in them. Syncona Partners was co-founded in 2012 by Martin Murphy and the Wellcome Trust, a charitable foundation based on healthcare research. In 2016, Syncona merged with the Battle Against Cancer Investment Trust (BACIT), becoming a FTSE 250 healthcare company and expanding its permanent capital base.
In 2013 The Cancer Research Technology Pioneer Fund (CPF), London Stock Exchange-listed investment company, BACIT Limited (BACIT), and drug discovery company, Sareum Limited (Sareum), entered into an agreement to co-fund the further development of a class of cancer drugs called CHK1 inhibitors.
Syncona went up from 152p to 154.4 p on yesterdays news re Quell but their model might also suit as an option for Sareum one day and they are obviously aware of us due to the history above.
Previous investments have been via issues of shares to raise capital for cta’s etc. Enough capital now therefore anyone else II or not needs to buy via the general market and the share price should benefit. I may be wrong but would be surprised to see another raising.
Last year an RNS was issued at the end of March notifying an extension and the report was issued at the end of April. The previous year the report was issued at the end of March. Any significance that this years is a full month in advance of the normal time?
The 2020 annual report (note 23 - page 42) showed there were 183,742,788 outstanding share options at a weighted average exercise price of 0.928p. The individual share options are shown on page 25 of the report with various amounts and prices over the years.
It was in a regular Daily Express article in 2005 ‘penny stocks to watch’ that they featured Sareum at the very early stage of their history - it encouraged me to get involved - hopefully the Mail article has a similar effect and helps the SP until the next news.
This is a recent interesting piece from someone who used to work with The Wellcome Trust.
https://uk.finance.yahoo.com/news/pension-funds-must-invest-uk-145345209.html
Just a thought. - many of us are sitting on a nice paper profit hoping for even better things in the near future. John and Tim have a great many outstanding options as well as owning just over 1.5% of the company each and these have taken on a significantly increased value over the last few months. Both of them have been deferring part of their salary in lieu of shares for the last year or so. Some options were exercised last year but the fact that there haven’t been any more movements should give us confidence.
2 new independent directors
“This is the ideal time for us to expand our Board with advisors who can help us not only transition into a commercial company, but also into a larger and diverse organization with multiple assets in its pipeline."
Like ‘multiple assets’